Clinic
Oscar F Sugastti, MD, LLC
Oscar F Sugastti, MD, LLC was paid $4.46M by Medicaid between Jan 2018 and Jul 2024, across 72 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoOSCAR F SUGASTTI, MD, LLC
WOODBRIDGE, VA 22191
WOODBRIDGE, VA 22191
33aNPI1942514435assigned 07/27/2010
33bProvider typePrimary Care Clinic/Center
28Total paid$4.46M
24GClaims162,268
24DCodes billed72
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Virginia
Rank by total paid#3 of 80
Median peer was paid$108K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,288 | $651K | |
| 2019 | 29,953 | $783K | |
| 2020 | 23,991 | $669K | |
| 2021 | 25,907 | $678K | |
| 2022 | 24,782 | $669K | |
| 2023 | 28,038 | $780K | |
| 2024incomplete | 8,309 | $235K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 27,192 | 23,710 | $1.54M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 7,236 | 6,820 | $608K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.6% | 4,447 | 4,352 | $338K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.9% | 4,437 | 3,953 | $306K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 3,911 | 3,816 | $297K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.2% | 2,247 | 2,198 | $189K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.1% | 10,501 | 5,053 | $140K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 2,586 | 2,467 | $91K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 3,392 | 3,260 | $81K |
| 90651 | 1.7% | 1,788 | 1,746 | $75K | |
| 90670 | 1.7% | 2,732 | 2,646 | $74K | |
| 90686 | 1.6% | 6,377 | 6,175 | $71K |
60 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 4,806 | $64K |
| 90710 | 1.2% | 1,449 | $52K | |
| 90698 | <1% | 2,369 | $43K | |
| 90671 | <1% | 462 | $39K | |
| 90680 | <1% | 2,068 | $37K | |
| 99188 | <1% | 1,514 | $30K | |
| 90734 | <1% | 916 | $27K | |
| 92551 | <1% | 2,919 | $27K | |
| 87807 | <1% | 1,985 | $24K | |
| 90633 | <1% | 1,904 | $24K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,872 | $19K |
| 90744 | <1% | 1,517 | $18K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 212 | $17K |
| 99000 | <1% | 6,038 | $16K | |
| Q3014 | Telehealth originating site facility fee | <1% | 623 | $16K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,992 | $16K |
| 90672 | <1% | 958 | $15K | |
| 99381 | <1% | 204 | $14K | |
| 99177 | <1% | 3,795 | $14K | |
| 90620 | <1% | 259 | $14K | |
| 96127 | <1% | 2,843 | $13K | |
| 99442 | <1% | 280 | $11K | |
| 69210 | <1% | 293 | $11K | |
| 99050 | <1% | 912 | $10K | |
| 99173 | <1% | 3,343 | $8K | |
| 81003 | <1% | 2,720 | $6K | |
| 99354 | <1% | 261 | $6K | |
| 85018 | <1% | 2,205 | $5K | |
| 90715 | <1% | 338 | $5K | |
| 99383 | <1% | 58 | $5K | |
| 90688 | <1% | 415 | $5K | |
| 90696 | <1% | 313 | $5K | |
| 99441 | <1% | 166 | $4K | |
| 83655 | <1% | 408 | $4K | |
| 90700 | <1% | 325 | $4K | |
| 0071A | <1% | 98 | $4K | |
| 0072A | <1% | 80 | $3K | |
| 90648 | <1% | 218 | $2K | |
| 0001A | <1% | 53 | $2K | |
| 90677 | <1% | 45 | $2K | |
| 0002A | <1% | 38 | $2K | |
| 99443 | <1% | 28 | $2K | |
| 90461 | <1% | 90 | $1K | |
| 3008F | <1% | 28,519 | $1K | |
| 99051 | <1% | 330 | $747.30 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 46 | $699.88 |
| 86580 | <1% | 66 | $394.60 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 35 | $360.90 |
| 36416 | <1% | 2,190 | $335.18 | |
| 94760 | <1% | 233 | $317.59 | |
| 99070 | <1% | 75 | $270.00 | |
| 90685 | <1% | 17 | $234.94 | |
| A7006 | Administration set, with small volume filtered pneumatic nebulizer | <1% | 37 | $183.94 |
| 83718 | <1% | 15 | $138.00 | |
| 82465 | <1% | 15 | $75.45 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 27 | $36.18 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 37 | $32.95 |
| 91307 | <1% | 205 | $1.39 | |
| 91300 | <1% | 151 | $1.01 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 32 | $0.93 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUGASTTI, OSCAR (OWNER)